University of Massachusetts - Amherst
Access to Kidney Transplantation in Minority Populations
Principal Investigator: Larissa Myaskovsky, PhD,
University of New Mexico Health Sciences
​
Funded by the National Institute on Minority Health and Health Disparities (NIMHD)
​
Study Years: 2020-2025
Kidney transplantation (KT) is the optimal treatment for end-stage kidney disease. It reduces mortality, improves quality of life, and costs less than dialysis. Although people who identify as Hispanic/Latino or American Indian are referred for KT equally with non-Hispanic whites, they are less likely to be wait-listed or to undergo KT than people who identify as white and non-Hispanic.
This study assesses which of two interventions shown to increase completion rates for KT evaluation process is more effective at helping patients with end-stage kidney disease who face greater barriers to transplant listing overcome these barriers. .​Dr. Sarah Goff is a co-investigator on the study, providing expertise on qualitative data analysis and implementation science.
Related Reports & Publications
Contemporary Clinical Trials Communications, October 2022
Kidney transplant (KT) is the optimal treatment for kidney failure (KF), and although completion of KT evaluation is an essential step in gaining access to transplantation, the process is lengthy, time consuming, and burdensome. Furthermore, despite similar referral rates to non-Hispanic Whites, both Hispanic/Latinos and American Indians are less likely to be wait-listed or to undergo KT.
​
The Access to Kidney Transplantation in Minority Populations (AKT-MP) Trial compares two patient-centered methods to facilitate KT evaluation: kidney transplant fast track (KTFT), a streamlined KT evaluation process; and peer navigators (PN), a peer-assisted evaluation program that incorporates motivational interviewing.